6 results
2019 EULAR recommendations for thrombosis in (Antiphospholipid Syndrome) APS
Venous Thrombosis - Arterial Thrombosis
INR Target
Duration
Recurrence

Dr. Laurent ARNAUD
) APS Venous Thrombosis ... INR Target Duration ... #APS #management ... #rheumatology #hematology ... #treatment
Venous Thrombosis vs Arterial Thrombosis - Differential Diagnosis Framework

VENOUS THROMBOSIS

 • Acquired Risk Factors:
	- >48 hours
Venous Thrombosis ... Diagnosis Framework VENOUS ... • Nephrotic Syndrome ... #Embolism #Venous ... pathophysiology #hematology
Clotmaster Consensus 2019: Duration of Therapy for Venous Thromboembolic Disease
 • Superficial Venous Thrombosis
 • Upper
Consensus 2019: Duration ... of Therapy for Venous ... • Superficial Venous ... syndrome - ... #length #treatment
Hepatopulmonary Syndrome - Diagnosis and Management Summary
A defect in arterial oxygenation due to a gas exchange
Hepatopulmonary Syndrome ... 10 minutes of rest ... ) on room air Treatment ... hepatopulmonary #syndrome ... #hepatology
Antiphospholipid Syndrome (APLS) Testing - Hypercoagulable Workup Algorithm
INDICATIONS FOR TESTING:
 • Vascular thrombosis
Antiphospholipid Syndrome ... Hypercoagulable Workup Algorithm ... episodes of arterial, venous ... or small-vessel thrombosis ... #diagnosis #hematology
Essential Thrombocythemia (ET)
ET is a chronic myeloproliferative neoplasm. Most cases are related to mutations that affect
erythromelalgia • Thrombosis ... ET-associated mutation ... • Treatment algorithms ... (if history of venous ... thrombosis)